{"id":7777,"date":"2026-07-10T10:18:47","date_gmt":"2026-07-10T10:18:47","guid":{"rendered":"https:\/\/en.fpi-inc.com\/?p=7777"},"modified":"2026-07-15T08:52:42","modified_gmt":"2026-07-15T08:52:42","slug":"fpi-automated-capillary-electrophoresis-trusted-by-hospitals-worldwide","status":"publish","type":"post","link":"https:\/\/en.fpi-inc.com\/fr\/fpi-automated-capillary-electrophoresis-trusted-by-hospitals-worldwide\/","title":{"rendered":"\u00c9lectrophor\u00e8se capillaire automatis\u00e9e FPI : pl\u00e9biscit\u00e9e par les h\u00f4pitaux du monde entier"},"content":{"rendered":"

After years of dedicated research and development, GETOTEC \u2014 a subsidiary of FPI\u2014 has successfully launched the ClinCap 1000 Fully Automated Capillary Electrophoresis System. Driven by targeted algorithmic advancements aimed at addressing the screening of thalassemia, M-protein, and other genetic and hematological conditions, the system is capable of detecting a broad spectrum of blood disorders. To date, the ClinCap 1000 has been deployed in Vietnam and the Republic of Congo, bringing accessible and reliable diagnostic solutions to underserved healthcare markets.<\/p>\n\n\n\n

At a general hospital in Hanoi, Vietnam, the ClinCap 1000 fully automated capillary electrophoresis system \u2014 developed by GETOTEC, a subsidiary of FPI \u2014 has been deployed and is operating reliably in clinical settings. The system supports a broad range of diagnostic applications, including serum protein electrophoresis (SPE), immunotyping (IT), hemoglobin electrophoresis (Hb Electrophoresis), and glycated hemoglobin testing (HbA1c). Certified to both ISO and CE standards, the ClinCap 1000 provides local clinicians with a robust and trusted foundation for accurate clinical diagnosis.<\/p>\n\n\n\n

\"\"
Quick and easy process<\/figcaption><\/figure>\n\n\n\n
\"\"
ClinCap 1000 System Architecture<\/figcaption><\/figure>\n\n\n\n

Addressing the challenges of Vietnam’s diverse local genotype distribution and complex sample structures, our engineering team conducted hands-on demonstrations using real hospital samples \u2014 combining on-site training with remote collaboration to enable medical staff to quickly master the instrument while ensuring stable operation.<\/p>\n\n\n\n

\u00b7 Installation & Parameter Optimization:<\/strong> Following instrument installation and calibration, the team performed parameter customization based on the hospital’s actual samples, ensuring clinical staff could operate the equipment proficiently.<\/p>\n\n\n\n

\u00b7 On-site & Remote Collaborative Support:<\/strong> Through a combination of on-site training and remote coordination, the team continuously refined the recognition stability of complex peak profiles.<\/p>\n\n\n\n

\"\"
GETOTEC’s fully automated capillary electrophoresis system runs stably at a hospital in Hanoi, Vietnam<\/figcaption><\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n

In the Republic of Congo, thalassemia stands as one of the predominant hematological disorders. The fully automated electrophoresis analyzer is precisely aligned with local healthcare demands. Paired with the proprietary software operating system developed by Jutuo, the system delivers pathological insights to assist physicians in clinical decision-making and automatically generates diagnostic reports \u2014 saving valuable time for both doctors and patients.stability of complex peak profiles.<\/p>\n\n\n\n

\"\"
On-Site Thalassemia Screening Program<\/figcaption><\/figure>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"

After years of dedicated research and development, GETOTEC \u2014 a subsidiary of FPI\u2014 has successfully launched the ClinCap 1000 Fully Automated Capillary Electrophoresis System. Driven by targeted algorithmic advancements aimed at addressing the screening of thalassemia, M-protein, and other genetic and hematological conditions, the system is capable of detecting a broad spectrum of blood disorders. To date, […]<\/p>\n","protected":false},"author":3,"featured_media":7799,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33],"tags":[],"class_list":["post-7777","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/en.fpi-inc.com\/fr\/wp-json\/wp\/v2\/posts\/7777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/en.fpi-inc.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/en.fpi-inc.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/en.fpi-inc.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/en.fpi-inc.com\/fr\/wp-json\/wp\/v2\/comments?post=7777"}],"version-history":[{"count":3,"href":"https:\/\/en.fpi-inc.com\/fr\/wp-json\/wp\/v2\/posts\/7777\/revisions"}],"predecessor-version":[{"id":7787,"href":"https:\/\/en.fpi-inc.com\/fr\/wp-json\/wp\/v2\/posts\/7777\/revisions\/7787"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/en.fpi-inc.com\/fr\/wp-json\/wp\/v2\/media\/7799"}],"wp:attachment":[{"href":"https:\/\/en.fpi-inc.com\/fr\/wp-json\/wp\/v2\/media?parent=7777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/en.fpi-inc.com\/fr\/wp-json\/wp\/v2\/categories?post=7777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/en.fpi-inc.com\/fr\/wp-json\/wp\/v2\/tags?post=7777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}